PureTech Health - Stock Price History | PRTC

Historical daily share price chart and data for PureTech Health since 2021 adjusted for splits. The latest closing stock price for PureTech Health as of September 27, 2021 is 51.89.
  • The all-time high PureTech Health stock closing price was 64.00 on March 30, 2021.
  • The PureTech Health 52-week high stock price is 65.90, which is 27% above the current share price.
  • The PureTech Health 52-week low stock price is 33.00, which is 36.4% below the current share price.
  • The average PureTech Health stock price for the last 52 weeks is 51.97.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
PureTech Health Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 44.9326 38.5000 54.0000 38.5000 54.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.487B $0.012B
PureTech Health plc is a clinical-stage biotherapeutics company. It engages in discovering, developing and commercializing medicines for devastating diseases, including inflammatory and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. PureTech Health plc is based in Boston, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29